Histone deacetylases (HDACs) catalyze the removal of acetyl molecules from histone and non-histone substrates playing important roles in chromatin remodeling and control of gene expression. Class I HDAC1 is a critical regulator of cell cycle progression, cellular proliferation and differentiation during development; it is also regulated by many post-translational modifications (PTMs). Herein we characterize a new mitosis-specific phosphorylation of HDAC1 driven by Aurora kinases A and B. We show that this phosphorylation affects HDAC1 enzymatic activity and it is critical for the maintenance of a proper proliferative and developmental plan in a complex organism. Notably, we find that Aurora-dependent phosphorylation of HDAC1 regulates histone acetylation by modulating the expression of genes directly involved in the developing zebrafish central nervous system. Our data represent a step towards the comprehension of HDAC1 regulation by its PTM code, with important implications in unravelling its roles both in physiology and pathology.
Histone deacetylases (HDACs) are enzymes which remove acetyl moieties from ε-NH3 groups of lysines from both nucleosomal histones and non-histone proteins1; they are also known as “lysine deacetylases” (K[Lys]DAC)2. In humans, 18 HDACs have been identified and are divided into four classes. Class I, II and IV all include Zn2+-dependent enzymes3. Class III includes NAD+-dependent HDACs called Sirtuins (Sirt1-7)4. Class I HDACs, which include HDAC1, 2, 3 and 8 are ubiquitously expressed in all tissues5 and have predominantly nuclear localization. The highly related HDAC1 and HDAC2 proteins are crucial for development and physiology of the heart6. They are also central regulators of cell cycle progression, apoptosis and cellular proliferation. Recent evidence has shown how the fine regulation of HDAC1 and HDAC2 protein levels and the maintenance of a proper balance between the two enzymes are critical in tumour onset and progression7,8,9,10. Thus, together with HDAC2, HDAC1 is believed to be one of the master regulators of chromatin acetylation and gene expression.
HDAC1 knockout mice die at embryonic day 9.5 (E9.5)11. Different human cancer cell lines depleted of HDAC1 have an aberrant cell cycle, accompanied by loss of mitotic cells and an increase in apoptosis12. HDAC1 and HDAC2 regulate G1/S transition by binding to p21WAF/CIP1 and p57Kip2 promoters13,14, whereas inhibition of HDAC enzymatic activities by trichostatin A (TSA)15 or depletion of HDAC1/HDAC2 affects the G2/M progression12. HDAC1 and HDAC2 often display redundant roles and compensatory effects. For example, differentiation of neurons from neuronal precursors requires either HDAC1 or HDAC216, while concomitant deletion of both deacetylases causes mitotic catastrophe with consequent cell death17. Consistently, depletion of either HDAC1 or HDAC2 in cancer cells induces a compensatory upregulation of HDAC2 or HDAC1 respectively17.
In zebrafish, Hdac1 is specifically required to promote neuronal specification in the developing Central Nervous System (CNS)18,19,20,21. Hdac1 is also needed for the switch from proliferation to differentiation in the zebrafish retina and optic stalk. It promotes cell cycle exit by antagonizing Notch and Wnt signaling pathways, correlating with cyclins D1 and E2 repression and leading to CDK inhibitor expression and neural progenitors cell cycle exit20,21. More in general, in zebrafish Hdac1 can function either as a positive or as a negative regulator of the cell cycle, depending on the tissue and the cell type in which it is active.
HDAC1 is a target of a complex code of post-translational modifications (PTMs, fully reviewed in ref. 22). Most recently, we have uncovered a SUMO-dependent mechanism that regulates its protein stability and expression in cancer cells23 and a novel phosphorylation of HDAC1 mediated by mitogens, describing a cross-talk between HDAC1 and PI3K pathways with clinical implications towards the treatment of cancer24. In this study we characterize an Aurora kinases-dependent, mitosis specific phosphorylation occurring on HDAC1, whose biological significance is further underscored by the fact that some viruses induce hyperphosphorylation of this HDAC at the same residues during the early phases of infection25,26,27. Furthermore, we provide evidence that this phosphorylation modulates the activity of HDAC1 and plays a role in regulating the proper cell cycle progression and developmental plan of zebrafish embryos. Our results contribute to elucidate how HDAC1 function may be finely regulated by a PTM, shedding light on the rationale of single HDACs regulation.
Aurora kinases phosphorylate HDAC1 in mitosis and regulate its enzymatic activity
It has been long known that HDAC1 is a critical player for the correct progression of cell cycle, but knowledge on how it is regulated remains poor. To gain insights into the molecular mechanisms, we analyzed by SDS-PAGE HDAC1 protein levels and mobility during cell cycle (Fig. 1a). HeLa cells were synchronized in different phases of the cell cycle as described in Supplementary Methods. Uniquely in mitotic cells, we observed the appearance of a slow-migrating band for HDAC1, but not for the less related class I HDAC3. Next, to better analyze the appearance of this modified form of HDAC1 as cells proceeded towards mitosis, HeLa cells were synchronized at the G1/S boundary by a double thymidine block, released in fresh medium containing nocodazole and samples were collected every hour (Supplementary Fig. S1a). The modified form of HDAC1 appeared after 7 hours, when cells started to enter mitosis and the maximum level of modification peaked at 9 hours corresponding to the maximal level of phospho-serine10-H3 (H3S10ph), a known marker of mitosis28. To evaluate the disappearance of the modified form of HDAC1, a purified mitotic population was released from nocodazole block, in fresh medium, to allow it to re-enter in a new G1 and samples were collected at the indicated times (Supplementary Fig. S1a). The same time-course was also performed on U2OS cells, with similar results (data not shown). The slow-migrating band of HDAC1 was likely due to a post-translational modification. It is well established that in mitosis there is a massive wave of phosphorylation for thousands of protein substrates29. Moreover, a previous study showed that the treatment of cells with the phosphatase inhibitor okadaic acid, which induces mitotic arrest, caused the appearance of a hyper-phosphorylated form of HDAC130. We thus performed in vitro phosphatase assays using lambda phosphatase on extracts isolated from asynchronous and mitotic HeLa cells. As shown in Supplementary Fig. S1b, mitotic slow-migrating bands were lost after treatment with phosphatase, indicating that the slower migration of HDAC1 was indeed caused by phosphorylation. Similar results were obtained by treating mitotic samples with Antarctic phosphatase31 or Calf Intestinal Phosphatase32. Mitotic phosphorylation of HDAC1 was detected also in other cell types: 293T fibroblasts, U2OS and Saos-2 osteosarcoma cells, normal and tumoral primary human breast cells, independently from their p53 expression (data not shown) indicating that mitotic phosphorylation of HDAC1 is a general hallmark of mitosis. We thus focused on kinases activated specifically in this phase to identify the one(s) involved in this phosphorylation. Among the mitotic-restricted kinases, putative predicted consensus sites for Plk1 (Polo-like kinase 1) (serine 236 for HDAC1) and Aurora A/B kinases (serine 406 for HDAC1) were identified (Supplementary Fig. S1c). We then synchronized HeLa cells in G1/S by a thymidine block and cells were released in fresh medium for 4 hours, synchronized in mitosis by nocodazole with or without the Aurora kinase inhibitors Hesperadin or ZM-447439 or the Plk1 inhibitor BI-2536; in the last hour of treatment, we added proteasome inhibitor MG132. Mitotic cells were collected after 5.5 hours and cell lysates were analyzed. As shown (Supplementary Fig. S1d), the phosphorylated forms of HDAC1 disappeared after inhibition of Aurora kinase activity. In contrast, inhibition of Plk1 had no effect on the mitotic phosphorylation of HDAC1 but impaired the phosphorylation of its known substrate Cdc25c. Our data indicated that Aurora kinases are likely the kinases responsible for HDAC1 mitotic phosphorylation, while Plk1 had no detectable role. Moreover, partial colocalization of HDAC1 and Aurora A in mitosis had been previously reported33. To formally address this point, we performed RNA interference to specifically knock down Aurora A and B, alone or in combination, and looked at the effect on the mitotic phosphorylated fractions of HDAC1. HeLa cells were subjected to two cycles of RNA interference using siRNA, while concomitantly synchronizing them at the G1/S boundary by double thymidine block, as schematized in Fig. 1b. After the second block, cells were released in nocodazole containing medium to enrich for the mitotic population: mitotic phosphorylation of HDAC1 was reduced when single Aurora A or B were knocked down, with an even greater reduction when both kinases were simultaneously depleted (Fig. 1b and Supplementary Fig. S1e). These data confirmed the specific involvement of Aurora kinases in mitotic phosphorylation; moreover, they also showed that in vivo HDAC1 phosphorylation can be driven by both Aurora A and B kinases.
To assess whether Aurora A and B could directly modify HDAC1, we performed an in vitro kinase assay using recombinant Aurora A/TPX2 or Aurora B/INCENP as enzymes and HDAC1, HDAC3 or histone 3 as substrates in the presence of [32P]-γ-ATP. The proteins were then separated by SDS-PAGE and the gel was exposed for autoradiography (Supplementary Fig. S1f). We observed that HDAC1 is phosphorylated by both Aurora A and Aurora B, in accordance with the in vivo data (Fig. 1b and Supplementary Fig. S1d,e). HDAC3, as expected, was neither modified by Aurora A nor B (Supplementary Fig. S1a,d,f). By mutagenesis assays (Supplementary Fig. S1g), we then corroborated that HDAC1 is phosphorylated in vitro on serine 406 by both Aurora A and Aurora B. Phosphorylation of serine 406-HDAC1 (S406A) by Aurora B in vitro was also confirmed by mass spectrometry after in vitro kinase assay31. To further validate the identified phosphorylation sites, Flag-tagged HDAC1 wild type and HDAC1 S406A mutant were expressed in HeLa cells and analyzed during mitosis (Fig. 1c). As expected, HDAC1 wild type showed the corresponding slow-migrating phosphorylated forms, which were lost in the mutant. Furthermore, using the BT-15 antibody31 that specifically recognizes serine 406 phosphorylation on HDAC1 we clearly detected this modified form of HDAC1 only in untreated mitotic samples (Supplementary Fig. S1b). Finally, enzymatic activity assays carried out in mitotic cells showed reduced enzymatic activity of the phospho-mimetic form of HDAC1 S406E compared to wild type (Fig. 1d). Altogether, these data suggest that HDAC1 is phosphorylated specifically in mitosis by Aurora kinases A and B and this modification modulates the deacetylase activity of the enzyme.
HDAC1 Aurora-dependent phosphorylation is critical for a proper developmental plan and controls the accurate cell cycle progression of zebrafish embryos
In many cellular systems, due to the well-known compensation mechanism between HDAC1 and HDAC2, depletion of HDAC1 leads to an increased level of HDAC2 protein and vice versa11,12,13. Unlike mammals, zebrafish do not possess two distinct HDAC1 and HDAC2 genes, but they only have one, which is more similar to human HDAC1 in terms of amino acidic sequence. Perfectly coordinated and regulated cell cycles are the conditio sine qua non for the proper completion of a developmental program and also very slight differences likely may have dramatic impact. Moreover, many studies have pointed out the crucial role of Hdac1 during zebrafish development, in particular of the nervous system, the retina and the optical stalk20. Thus, to investigate the possible biological role of mitotic HDAC1 phosphorylation we used zebrafish embryos as a model. Our experimental approach consisted in knocking down the endogenous hdac1 in zebrafish embryos right after fertilization using the morpholino strategy and reinserting the human HDAC1 wild type or Aurora phospho mutants S406A or S406E mRNA (Fig. 2a, the left panel of Supplementary Fig. S2a). We observed that the injection of a scramble morpholino did not affect the morphology of 72 hpf (hours post fertilization) embryos. On the contrary, as already known34, hdac1 MO injected embryos displayed multiple developmental and morphological defects due to the absence of Hdac1: reduced size of head (hd) and jaw (j), curled down tail (ct); moreover, a pericardial edema (pe) was clearly visible. Also pectoral fins (pf) were missing, otoliths (*) were smaller and close together and melanocyte migration was defective. The expression of the human HDAC1 wt by co-injection of its mRNA together with hdac1 MO significantly rescued the morphants phenotype: 90% of the embryos (out of 120) displayed a wild type-like phenotype with relatively normal heads, eyes and jaw structures and a straight antero-posterior body axis; reabsorption of the pericardial oedema, proper melanocyte distribution and an outline of pectoral fins are visible. Interestingly, the human Aurora phospho-null S406A mutant only partially rescued essential features of the morphant phenotype. In fact, although reduced head size, absence of pectoral fins and cell migration defects observed in morphant embryos still persisted, a proper body axis and pericardial oedema were recovered. Notably, all the body structures showed a striking developmental delay, as indicated by the late migration of the head melanocytes and yolk reabsorption. About 56% of hHDAC1 S406A injected embryos (out of 80) showed a wild type-like phenotype. Conversely, the expression of the human phospho-mimetic HDAC1 S406E was not able to rescue the phenotype in an hdac1 morpholino background: strong defects in the development of the head and the eye were present, pericardial oedema was not reabsorbed and jaw and pectoral fins failed to form. Furthermore, there was no recovery in the body axis: a curled down tail was present and a random distribution of melanocytes was visible, particularly in the head. About 70% of the hHDAC1 S406E injected embryos (out of 70) had an hdac1 MO-like phenotype. We verified the expression of the injected human proteins in an hdac1 MO background (the right panel of Supplementary Fig. S2a) and using the BT-15 antibody31, we assessed whether also the zebrafish orthologs of the human Aurora kinases (Supplementary Fig. S2b) were able to phosphorylate hHDAC1 in zebrafish embryos. Zebrafish embryos were injected with hdac1 morpholino alone or in combination with hHDAC1 Aurora phospho mutants, collected at 24 hpf and immunostained with BT-15 antibody. As expected, in embryos injected with a scramble morpholino no BT-15 positive cells were detected (Supplementary Fig. S3a). This was due to the high specificity of the antibody for the human form of HDAC1 (human and zebrafish HDAC1 protein differ by a 4 amino acids mismatch in the BT-15 epitope (Supplementary Fig. S2b)). Embryos co-injected with hdac1 morpholino and hHDAC1 wt displayed a limited number of BT-15 positive cells: indeed, among all the mitotic (H3S10ph positive) cells, only prophase cells were recognized by the HDAC1 pS406 antibody (Supplementary Fig. S3a,b), as expected from our mammalian data which show HDAC1 Aurora-dependent phosphorylation in prophase31. Moreover, the injection of the phospho null mutant hHDAC1 S406A in a hdac1 morpholino background completely abolished the BT-15 staining; on the contrary, the hHDAC1 S406E mutant mimicked the Aurora driven phosphorylation of the protein31, and therefore all the cells of the embryos injected with hdac1 MO plus hHDAC1 S406E were BT-15 positive, independently of the phases of the cell cycle.
Given the well-established role of HDAC1 in controlling cell cycle and proliferation, we then monitored cell cycle progression at 72 hpf in embryos expressing hdac1 MO alone or in combination with human HDAC1 Aurora-phospho mutants and in control by Propidium Iodide (PI) staining and fluorescence-activated cell sorting (FACS) analyses. Comparing cell populations of embryos heads between scramble and hdac1 morphant embryos, we found a high and significant reduction in the G2-M populations and a corresponding increase in interphase cells (Fig. 2b). There was nearly the same change in cell cycle distribution upon co-injection of the hdac1 MO and hHDAC1 S406E, suggesting that the phospho-mimetic hHDAC1 mutant failed to revert the cell cycle progression phenotype of hdac1 morphant embryos. On the contrary, comparing cells from heads of control embryos and embryos co-injected with hdac1 MO and hHDAC1wt or hHDAC1 S406A mutant, we could not detect any differences in cell cycle progression at 72 hpf. Taken together these results indicated that a proper balance of the Aurora-driven phosphorylation of HDAC1 is critical for the maintenance of a proper proliferative and developmental plan in a complex organism.
HDAC1 Aurora-dependent phosphorylation regulates histone acetylation in hdac1 morphant embryos and controls expression of CNS regulatory genes during zebrafish development
To test whether the Aurora-dependent phosphorylation of HDAC1 is important in controlling the deacetylase activity of the enzyme in vivo, we performed immunohistochemistry experiments. Sections of hdac1 morphant embryos or embryos injected with hdac1 MO + hHDAC1 wt, S406A or S406E mutants were immunostained with (K8, K12) acetyl-Histone H4 antibody9,35 and the acetylation levels were compared to those of control embryos at 72 hpf, where there was complete abrogation of maternal hdac1 (the left panel of Supplementary Fig. S2a). To make the data quantitatively and qualitatively comparable, for the counting of positive cells we decided to consider the same brain region of 72 hpf embryos for all samples, in particular the developing diencephalon, which is located between the eyes (Fig. 3a, denoted as “d”, and Supplementary Fig. S4). Observing the brain morphology in the sections of morphant embryos, a dramatic effect of Hdac1 KD on brain architecture is clearly visible, mainly due to an abnormal enlargement of the brain ventricles (bv) that compresses the surrounding tissues. Moreover, the analysis of embryos sections confirmed that hHDAC1 wt mRNA rescued almost completely the morphology of the brain caused by the KD of endogenous Hdac1, while the injection of the two hHDAC1 Aurora mutants mRNAs only weakly rescued Hdac1 KD (hHDAC1 S406A) or did not rescue at all the morphant phenotype (hHDAC1 S406E). As expected, knock down of endogenous Hdac1 in morphant embryos increased the percentage of strong positive histone H4 acetylated (acH4) cells compared to uninjected embryos20,36. Interestingly, we observed a significant increase in the acetylation level in the diencephalon of embryos injected with hdac1 MO + hHDAC1 S406E in comparison to both controls (uninjected and hdac1 MO + hHDAC1 wt), suggesting that also in an in vivo model the Aurora phospho-mimetic form of hHDAC1 failed to deacetylate its substrates. Conversely, embryos co-injected with hdac1 MO + hHDAC1 wt or hdac1 MO + hHDAC1 S406A, were able to restore the acetylation level in 72 hpf embryos brain. Control experiments were also performed to check the expression of human HDAC1 wt and mutants in injected embryos; as shown in the right panel of Supplementary Fig. S2a all three constructs were properly expressed. Notably, hHDAC1 wt expression was stronger compared to the two mutants; this might also explain the lower level of histone H4 acetylation in hHDAC1 wt samples compared to uninjected.
We then asked whether HDAC1 Aurora mutants exert their regulation by an epigenetic mechanism. To verify this hypothesis, we performed on heads of 72 hpf embryos injected at one-cell stage, with hdac1 MO alone or in combination with hHDAC1 wt, S406A or S406E, a chromatin immunoprecipitation (ChIP) experiment with anti-acetylated lysine H3K27 antibody. The ChIP experiment was coupled to quantitative real-time PCR (RTqPCR) to evaluate the enrichment in the acetylation of the promoter of selected genes compared to their input (Supplementary Table S2). The genes used for the quantitative analysis were chosen from a list of genes involved in zebrafish developing CNS and retina, whose expression significantly changed upon hdac1 ablation36. Figure 3b displays the trend of acetylated promoters of ten genes under hdac1 knock down and/or complementation with the hHDAC1 Aurora phospho mutants. Ablation of the endogenous Hdac1 led to an increased H3K27 acetylation level of each promoter of the genes compared to the IgG control; notably, acetylated H3K27 highly increased also upon co-injection of hdac1 MO together with hHDAC1 phospho-mimetic, supporting our previous findings of a reduced deacetylating activity for hHDAC1 S406E mutant. On the contrary, expression of hHDAC1 wt in morphant embryos completely restored the acetylation level in the promoter of the genes. To further validate our hypothesis, we checked the expression level of the genes selected for the ChIP analysis. To this aim, RNA was extracted from the heads of 72 hpf embryos injected right after fertilization with Scramble MO or hdac1 MO alone or in combination with hHDAC1 Aurora phospho-mutants and RTqPCR were performed to measure the expression level of our subset of genes (Supplementary Table S3).
As shown in Fig. 3c, the vast majority of the genes exhibit comparable expression levels upon ablation of the endogenous hdac1 or injection of hdac1 MO plus hHDAC1 S406E mutant; whereas the presence of hHDAC1 wt or S406A in a morpholino background almost completely restored the expression levels of the genes. Taken together, our data indicate that HDAC1 Aurora-dependent phosphorylation is involved in the control of the catalytic activity of the enzyme both regulating histone acetylation levels and modulating expression of neurogenic regulatory genes throughout the zebrafish developing CNS.
Proliferation and differentiation are two interconnected pathways, especially during development, where every event of cell division must be strictly regulated in space and time to successfully complete the developmental plan. Our hypothesis is the following (Fig. 4): as cells progress from G2 to metaphase, they need to condense their chromatin, monitor the process and correct any abnormalities in chromatin architecture. HDAC1 has an important role in this process since deacetylation of key residues, such as H3K9, is a prerequisite for mitotic DNA condensation, but at a certain point HDAC1 activity must be stopped and the enzyme displaced from chromatin32. Our data suggest that Aurora kinases phosphorylate HDAC1 in prophase, right after cells enter mitosis. This phosphorylation, by impacting on the deacetylase activity of the enzyme, has an effect on different levels: 1) on expression level, modulating histones’ acetylation and gene expression of CNS-related genes and 2) on proliferation level, controlling proper cell cycle progression. Therefore, the Aurora-driven phosphorylation of HDAC1 could represent a further mechanism by which cells control the balance between proliferation and differentiation to ensure the inheritance of important gene signatures in the next generation of cells.
Specifically, in physiological conditions, S406 HDAC1 phosphorylation, even though very dynamically, results in transiently increased promoter acetylation of genes expressed in the CNS or with CNS-oriented functions, thus modulating their expression and enabling an accurate embryos’ development.
Thereafter, the prompt removal of the phosphate group brings promoters’ acetylation and genes’ expression levels back to their basal state. In a more exacerbated condition, i.e. mimicking HDAC1 phosphorylation by replacing the wildtype protein with HDAC1 S406E, the enzyme is constitutively less active; thereby the promoters of above mentioned genes stay highly acetylated. This situation lasting for quite a long time causes an overall morphological impairment and most importantly does not allow cells to properly go through the cell cycle. Moreover, we reasoned that it is likely that cells, which miss S406-dephosphorylated HDAC1 display a prolonged interphase due to the increased expression of factors such a Gadd45aa. It has been shown that overexpression of the mammalian homolog Gadd45 prevents G1/S transition37,38. Alternatively or in addition, histone hyperacetylation in the absence of fully active S406-dephosphorylated HDAC1 might directly interfere with normal S-phase transition given the known role of HDAC1 in DNA replication39.
On the contrary, the absolute abrogation of the HDAC1 Aurora-dependent phosphorylation does not affect proper cell cycle progression, but embryos display a clear developmental delay probably due to the fact that expression of genes persists at basal levels. In conclusion, we hypothesize that while controlling the deacetylase activity of HDAC1, the Aurora-dependent phosphorylation on one hand modulates the expression of genes directly involved in zebrafish development, and, on the other hand, acts as sensor of the transcriptional process, regulating in a fine-tuned manner proper cell cycle progression.
Zebrafish strains and maintenance
Zebrafish strains were maintained and bred according to standard procedures. Embryos from AB wild type strain were maintained in E3 water (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, 0.33 mM MgSO4) at 28.5 °C.
Fish were maintained/raised according to EU regulations on laboratory animals.
All experimental protocols (project number 02/14) were approved by the Institutional Animal Care and Use Committee (IACUC) of IFOM (FIRC Institute of Molecular Oncology, Via Adamello 16, 20139, Milan Italy) and by the Italian Ministry of Health.
mRNAs and morpholino injections in zebrafish embryos
mRNAs were synthesized from NotI digested pCS2+hHDAC1 wt, S406A, S406E plasmids using mMessage mMachine kit (Ambion) and purified with Microcon YM-100 (Millipore) filter devices. RNA quality was assayed by means of gel electrophoresis. mRNAs was then diluted in 1X Danieau solution (58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO4, 0.6 mM Ca(NO3)2, 5 mM HEPES, pH 7.6) at final concentration of 120 ng/μl and pressure injected into 1–2 cell stage embryos.
Morpholinos were purchased by Gene Tools, LLC. The morpholino against hdac1 (5′-TTGTTCCTTGAGAACTCAGCGCCAT-3′) was targeted to the translational initiation site, as ref. 19. The scramble morpholino sequences was: 5′-CCTCTTACCTCAGTTACAATTTATA-3′. Morpholinos (0,15 mM) were diluted and injected as described above.
Chromatin immunoprecipitation (ChIP) and quantitative real-time PCR (RTqPCR)
Fixed head embryos cells were lysed in RIPA buffer and after chromatin shearing by sonication, incubated at 4 °C overnight with protein G Dynabeads (Invitrogen) and anti-acetylated H3K27 antibody (Abcam ab4729). Extended methods are in the Supplementary Information.
How to cite this article: Loponte, S. et al. Dynamic phosphorylation of Histone Deacetylase 1 by Aurora kinases during mitosis regulates zebrafish embryos development. Sci. Rep. 6, 30213; doi: 10.1038/srep30213 (2016).
Yang, X. J. & Seto, E. HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention. Oncogene 26, 5310–5318 (2007).
Yang, X. J. & Seto, E. The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men. Nat Rev Mol Cell Biol 9, 206–218 (2008).
de Ruijter, A. J., van Gennip, A. H., Caron, H. N., Kemp, S. & van Kuilenburg, A. B. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 370, 737–749 (2003).
Haigis, M. C. & Guarente, L. P. Mammalian sirtuins–emerging roles in physiology, aging, and calorie restriction. Genes Dev 20, 2913–2921, doi: 10.1101/gad.1467506 (2006).
Witt, O., Deubzer, H. E., Milde, T. & Oehme, I. HDAC family: What are the cancer relevant targets? Cancer Lett 277, 8–21, doi: 10.1016/j.canlet.2008.08.016 (2009).
Haberland, M., Montgomery, R. L. & Olson, E. N. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet 10, 32–42, doi: 10.1038/nrg2485 (2009).
Dovey, O. M. et al. Histone deacetylase 1 and 2 are essential for normal T-cell development and genomic stability in mice. Blood 121, 1335–1344, doi: 10.1182/blood-2012-07-441949 (2013).
Heideman, M. R. et al. Dosage-dependent tumor suppression by histone deacetylases 1 and 2 through regulation of c-Myc collaborating genes and p53 function. Blood, doi: 10.1182/blood-2012-08-450916 (2013).
Santoro, F. et al. A dual role for Hdac1: oncosuppressor in tumorigenesis, oncogene in tumor maintenance. Blood, doi: 10.1182/blood-2012-10-461988 (2013).
Winter, M. et al. Divergent roles of HDAC1 and HDAC2 in the regulation of epidermal development and tumorigenesis. Embo J 32, 3176–3191, doi: 10.1038/emboj.2013.243 (2013).
Lagger, G. et al. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. Embo J 21, 2672–2681 (2002).
Senese, S. et al. Role for histone deacetylase 1 in human tumor cell proliferation. Mol Cell Biol 27, 4784–4795 (2007).
Yamaguchi, T. et al. Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression. Genes Dev 24, 455–469, doi: 10.1101/gad.552310 (2010).
Zupkovitz, G. et al. The cyclin-dependent kinase inhibitor p21 is a crucial target for histone deacetylase 1 as a regulator of cellular proliferation. Mol Cell Biol 30, 1171–1181, doi: 10.1128/MCB.01500-09 (2010).
Noh, E. J., Lim, D. S., Jeong, G. & Lee, J. S. An HDAC inhibitor, trichostatin A, induces a delay at G2/M transition, slippage of spindle checkpoint, and cell death in a transcription-dependent manner. Biochem Biophys Res Commun 378, 326–331, doi: 10.1016/j.bbrc.2008.11.057 (2009).
Montgomery, R. L., Hsieh, J., Barbosa, A. C., Richardson, J. A. & Olson, E. N. Histone deacetylases 1 and 2 control the progression of neural precursors to neurons during brain development. Proc Natl Acad Sci USA 106, 7876–7881, doi: 10.1073/pnas.0902750106 (2009).
Haberland, M., Johnson, A., Mokalled, M. H., Montgomery, R. L. & Olson, E. N. Genetic dissection of histone deacetylase requirement in tumor cells. Proc Natl Acad Sci USA 106, 7751–7755, doi: 10.1073/pnas.0903139106 (2009).
Cunliffe, V. T. & Casaccia-Bonnefil, P. Histone deacetylase 1 is essential for oligodendrocyte specification in the zebrafish CNS. Mech Dev 123, 24–30, doi: 10.1016/j.mod.2005.10.005 (2006).
Lightman, E. G., Harrison, M. R. & Cunliffe, V. T. Opposing actions of histone deacetylase 1 and Notch signalling restrict expression of erm and fgf20a to hindbrain rhombomere centres during zebrafish neurogenesis. Int J Dev Biol 55, 597–602, doi: 10.1387/ijdb.113315el (2011).
Stadler, J. A. et al. Histone deacetylase 1 is required for cell cycle exit and differentiation in the zebrafish retina. Dev Dyn 233, 883–889, doi: 10.1002/dvdy.20427 (2005).
Yamaguchi, M. et al. Histone deacetylase 1 regulates retinal neurogenesis in zebrafish by suppressing Wnt and Notch signaling pathways. Development 132, 3027–3043, doi: 10.1242/dev.01881 (2005).
Segre, C. V. & Chiocca, S. Regulating the regulators: the post-translational code of class I HDAC1 and HDAC2. J Biomed Biotechnol 2011, 690848, doi: 10.1155/2011/690848 (2011).
Citro, S., Jaffray, E., Hay, R. T., Seiser, C. & Chiocca, S. A role for paralog-specific sumoylation in histone deacetylase 1 stability. J Mol Cell Biol 5, 416–427, doi: 10.1093/jmcb/mjt032 (2013).
Citro, S., Miccolo, C., Meloni, L. & Chiocca, S. PI3K/mTOR mediate mitogen-dependent HDAC1 phosphorylation in breast cancer: a novel regulation of estrogen receptor expression. J Mol Cell Biol 7, 132–142, doi: 10.1093/jmcb/mjv021 (2015).
Poon, A. P., Liang, Y. & Roizman, B. Herpes simplex virus 1 gene expression is accelerated by inhibitors of histone deacetylases in rabbit skin cells infected with a mutant carrying a cDNA copy of the infected-cell protein no. 0. J Virol 77, 12671–12678 (2003).
Walters, M. S., Erazo, A., Kinchington, P. R. & Silverstein, S. Histone Deacetylase 1 and 2 are Phosphorylated at Novel Sites During Varicella Zoster Virus Infection. J Virol 83, 11502–11513 (2009).
Walters, M. S., Kinchington, P. R., Banfield, B. W. & Silverstein, S. Hyperphosphorylation of histone deacetylase 2 by alphaherpesvirus US3 kinases. J Virol 84, 9666–9676, doi: 10.1128/JVI.00981-10 (2010).
Crosio, C. et al. Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian Aurora kinases. Mol Cell Biol 22, 874–885 (2002).
Dephoure, N. et al. A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci USA 105, 10762–10767 (2008).
Galasinski, S. C., Resing, K. A., Goodrich, J. A. & Ahn, N. G. Phosphatase inhibition leads to histone deacetylases 1 and 2 phosphorylation and disruption of corepressor interactions. J Biol Chem 277, 19618–19626 (2002).
Segre, C. V. et al. A monoclonal antibody specific for prophase phosphorylation of histone deacetylase 1: a readout for early mitotic cells. MAbs 8, 37–42, doi: 10.1080/19420862.2015.1098795 (2016).
Khan, D. H. et al. Protein kinase CK2 regulates the dimerization of histone deacetylase 1 (HDAC1) and HDAC2 during mitosis. J Biol Chem 288, 16518–16528, doi: 10.1074/jbc.M112.440446 (2013).
Sakai, H. et al. MBD3 and HDAC1, two components of the NuRD complex, are localized at Aurora-A-positive centrosomes in M phase. J Biol Chem 277, 48714–48723 (2002).
Nambiar, R. M., Ignatius, M. S. & Henion, P. D. Zebrafish colgate/hdac1 functions in the non-canonical Wnt pathway during axial extension and in Wnt-independent branchiomotor neuron migration. Mech Dev 124, 682–698, doi: 10.1016/j.mod.2007.07.003 (2007).
Ronzoni, S., Faretta, M., Ballarini, M., Pelicci, P. & Minucci, S. New method to detect histone acetylation levels by flow cytometry. Cytometry A 66, 52–61, doi: 10.1002/cyto.a.20151 (2005).
Harrison, M. R., Georgiou, A. S., Spaink, H. P. & Cunliffe, V. T. The epigenetic regulator Histone Deacetylase 1 promotes transcription of a core neurogenic programme in zebrafish embryos. BMC Genomics 12, 24, doi: 010.1186/1471-2164-12-24 (2011).
Fan, W., Richter, G., Cereseto, A., Beadling, C. & Smith, K. A. Cytokine response gene 6 induces p21 and regulates both cell growth and arrest. Oncogene 18, 6573–6582, doi: 10.1038/sj.onc.1203054 (1999).
Liebermann, D. A. et al. Gadd45 stress sensors in malignancy and leukemia. Crit Rev Oncog 16, 129–140 (2011).
Bhaskara, S. Histone deacetylases 1 and 2 regulate DNA replication and DNA repair: potential targets for genome stability-mechanism-based therapeutics for a subset of cancers. Cell Cycle 14, 1779–1785, doi: 10.1080/15384101.2015.1042634 (2015).
Pflum, M. K., Tong, J. K., Lane, W. S. & Schreiber, S. L. Histone deacetylase 1 phosphorylation promotes enzymatic activity and complex formation. J Biol Chem 276, 47733–47741 (2001).
We are very grateful to all lab members. We thank Alessandra Mancino and Sara Polletti for ChIP expertise, Anna De Antoni for providing kinase inhibitors. We are much appreciative to Prof. Andrea Musacchio insightful scientific expertise. We thank all the support facilities at IEO and IFOM, in particular Amanda Oldani and Sara Barozzi for technical support with imaging techniques and Federica Pezzimenti for initial technical support with zebrafish injections. This work was supported by AIRC (Associazione Italiana per la Ricerca sul Cancro, IG5732 and IG12075 to S.C.) and the Italian Ministry of Health to SC. CVS and S.Ci were supported by a FUV (Fondazione Umberto Veronesi) fellowship. S.S. was supported by fellowships from the Italian Foundation for Cancer Research (FIRC). R.V. was supported in part by an International Early Career Scientist grant from the Howard Hughes Medical Institute and C.S. by the Austrian Science Fund (FWF 25807).
The authors declare no competing financial interests.
About this article
Cite this article
Loponte, S., Segré, C., Senese, S. et al. Dynamic phosphorylation of Histone Deacetylase 1 by Aurora kinases during mitosis regulates zebrafish embryos development. Sci Rep 6, 30213 (2016). https://doi.org/10.1038/srep30213
Cardiac troponin I R193H mutant interacts with HDAC1 to repress phosphodiesterase 4D expression in cardiomyocytes
Genes & Diseases (2021)
Cell Death & Disease (2021)
Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastoma
Emerging roles of metazoan cell cycle regulators as coordinators of the cell cycle and differentiation
FEBS Letters (2020)
Genome Survey of Chromatin-Modifying Enzymes in Threespine Stickleback: A Crucial Epigenetic Toolkit for Adaptation?
Frontiers in Marine Science (2019)